Literature DB >> 15307138

The role of Notch receptor expression in bile duct development and disease.

Diana M Flynn1, Sarbjit Nijjar, Stefan G Hubscher, Jean de Ville de Goyet, Deirdre A Kelly, Alastair J Strain, Heather A Crosby.   

Abstract

Mutations in the Jagged1 gene, a ligand for the Notch signalling pathway, have been implicated in the pathogenesis of Alagille syndrome (AGS), resulting in bile duct paucity. Recently, a mouse model for AGS suggested that abnormalities of the Notch2 receptor, as well as of Jagged1, may be present. Expression patterns of Notch receptors have not been described in the developing human liver or in paediatric liver. The expression of Notch receptors and ligands was examined in fetal, paediatric normal, and diseased human liver by RT-PCR and immunohistochemistry. RT-PCR showed Notch1-4 mRNA expression to be present. In fetal liver, Notch3 protein was expressed on mesenchymal cells, closely adjacent to ductal plate cells that expressed Jagged1. In paediatric normal liver, Notch1 and Notch2 were present on mature bile duct cells. Notch expression was altered in disease, with distinct differences in AGS from extrahepatic biliary atresia (EHBA) and alpha1-anti-trypsin deficiency (alpha1AT). In AGS, where extensive ductular reaction was present, Jagged1 was expressed on ductular reactive cells (DRCs), along with marked Notch2 and Notch3 staining. Where there was ductular paucity, Notch2 and Notch3 were not expressed on remaining biliary epithelial cells. In EHBA and alpha1AT, Notch receptor expression was not seen on DRCs. Instead, Notch2 and Notch3 were expressed by stromal cells. In all diseases, Notch3 was expressed on neovessels in portal tracts and cirrhotic fibrous septa. In conclusion, Notch3 is expressed in close proximity to Jagged1 at the time of ductal plate formation, suggesting that Notch3 is important for bile duct development. The expression of both Notch2 and Notch3 in AGS on DRCs confirms that these receptors may be important in the pathogenesis of this disease. Further studies are required to investigate the presence of Notch2 and Notch3 at other periods in liver development and to clarify the role of Notch signalling in paediatric cholestases. Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307138     DOI: 10.1002/path.1615

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes.

Authors:  Xiao Zhang; Guangli Du; Ying Xu; Xuewei Li; Weiwei Fan; Jiamei Chen; Cheng Liu; Gaofeng Chen; Chenghai Liu; Mark A Zern; Yongping Mu; Ping Liu
Journal:  Lab Invest       Date:  2015-12-21       Impact factor: 5.662

2.  Notch signaling controls liver development by regulating biliary differentiation.

Authors:  Yiwei Zong; Archana Panikkar; Jie Xu; Aline Antoniou; Peggy Raynaud; Frederic Lemaigre; Ben Z Stanger
Journal:  Development       Date:  2009-04-15       Impact factor: 6.868

3.  Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice.

Authors:  Mami Uemura; Aisa Ozawa; Takumi Nagata; Kaoruko Kurasawa; Naoki Tsunekawa; Ikuo Nobuhisa; Tetsuya Taga; Kenshiro Hara; Akihiko Kudo; Hayato Kawakami; Yukio Saijoh; Masamichi Kurohmaru; Masami Kanai-Azuma; Yoshiakira Kanai
Journal:  Development       Date:  2013-02-01       Impact factor: 6.868

4.  Loss of Anks6 leads to YAP deficiency and liver abnormalities.

Authors:  Merlin Airik; Markus Schüler; Blake McCourt; Anna-Carina Weiss; Nathan Herdman; Timo H Lüdtke; Eugen Widmeier; Donna B Stolz; Kari N Nejak-Bowen; Dean Yimlamai; Yijen L Wu; Andreas Kispert; Rannar Airik; Friedhelm Hildebrandt
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

Review 5.  Molecular mechanisms of bile duct development.

Authors:  Yiwei Zong; Ben Z Stanger
Journal:  Int J Biochem Cell Biol       Date:  2010-07-01       Impact factor: 5.085

Review 6.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. III. Implications for liver pathology.

Authors:  Valeer J Desmet
Journal:  Virchows Arch       Date:  2011-02-08       Impact factor: 4.064

7.  Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.

Authors:  Jennifer J Hofmann; Ann C Zovein; Huilin Koh; Freddy Radtke; Gerry Weinmaster; M Luisa Iruela-Arispe
Journal:  Development       Date:  2010-12       Impact factor: 6.868

Review 8.  [Cholestasis-associated hepatopathies in neonates and infants].

Authors:  G Knöpfle; A Adam; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

9.  Transcription factor GATA6: a novel marker and putative inducer of ductal metaplasia in biliary atresia.

Authors:  Tea Soini; Marjut Pihlajoki; Noora Andersson; Jouko Lohi; Kari A Huppert; David A Rudnick; Stacey S Huppert; David B Wilson; Mikko P Pakarinen; Markku Heikinheimo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-02-01       Impact factor: 4.052

10.  Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.

Authors:  Luca Fabris; Massimiliano Cadamuro; Maria Guido; Carlo Spirli; Romina Fiorotto; Michele Colledan; Giuliano Torre; Daniele Alberti; Aurelio Sonzogni; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.